Skip to main content
The Journal of Physiology logoLink to The Journal of Physiology
. 2015 Dec 7;593(24):5215–5217. doi: 10.1113/JP271041

CrossTalk proposal: High intensity interval training does have a role in risk reduction or treatment of disease

Ulrik Wisløff 1,, Jeff S Coombes 2, Øivind Rognmo 1
PMCID: PMC4704521  PMID: 26642190

Traditionally the effect of exercise training and physical activity (PA) on risk classification and on the treatment of diseases has been studied at low to moderate exercise intensities (Fletcher et al. 2013; Levinger et al. 2015). However, in the last 15 years a growing body of evidence has suggested that exercise at high intensity may be equally effective, and in many cases outperform low to moderate intensities in terms of treatment effects and risk reduction (Swain & Franklin, 2006).

Epidemiological evidence of the importance of high intensity training in risk reduction

Epidemiological studies that compare the effect of physical activity of different intensities on all‐cause and disease‐specific mortalities demonstrate that the effect of moderate intensity is highly beneficial, but they also show that high‐intensity exercise may induce larger health benefits, relative to the time spent on physical activity (Gebel et al. 2015). For instance, a study from Taiwan of more than 400,000 individuals demonstrated that 15 min of vigorous PA daily gave similar all‐cause mortality risk reduction (∼25%) to 60 min of moderate intensity PA daily (Wen et al. 2011). In line with these results we found that a single weekly bout of physical activity at high intensity (∼90% of peak heart rate) gave similar or higher protection against premature all‐cause and cardiovascular mortality compared to several hours of moderate intensity exercise (Wisloff et al. 2006). These data are also supported by Lee et al. (2003), who found an inverse association between the relative intensity of physical activity and risk of coronary heart disease among men not satisfying current physical activity recommendations.

Peak oxygen uptake (V˙O2 peak ) is one of the strongest prognostic markers for future cardiovascular health and premature mortality (Myers et al. 2002; Keteyian et al. 2008; Nes et al. 2014). Interestingly, although physical activity levels are also associated with mortality, this association disappears after adjustment for V˙O2 peak (Lee et al. 2011). Considering the strong association between V˙O2 peak and health, it is important to know which type of exercise training is the most effective for improving fitness. There is strong epidemiological evidence that PA at high intensity gives substantially larger improvements in fitness. For instance, it is reported that Norwegian men with ∼49 min per week of very vigorous exercise (defined as > 90% of V˙O2 peak ) achieved almost ∼2 metabolic equivalent of task (MET) (6 ml kg−1 min−1) higher V˙O2 peak compared with those exercising at moderate intensities (∼70% of V˙O2 peak )(Nes et al. 2012). Even over 216 min per week of moderate intensity exercise gave V˙O2 peak levels that were about ∼1 MET (3.5 ml kg−1 min−1) lower than that obtained performing very‐vigorous PA weekly for 49 min (Fig. 1). Similar findings were observed in women. From epidemiological studies there is now substantial evidence that high‐intensity PA has an equal or better effect in risk reduction for cardiovascular disease, ischaemic heart disease, stroke, some types of cancer and type 2 diabetes.

Figure 1. Weekly exercise time and peak oxygen uptake in ( V˙O2 peak ) 2263 men performing physical activity regularly at different intensities .

Figure 1

Low intensity: Borg scale 6–11, ∼40–65% of V˙O2 peak ; moderate intensity: Borg scale 12–13, ∼70% of V˙O2 peak ; vigorous: Borg scale 14–15, 80–90% of V˙O2 peak ; very vigorous: Borg scale 16–20, > 90% of V˙O2 peak . Figure modified from Nes et al. (2012).

Clinical and experimental data on high‐intensity interval training's role in treatment of disease

In a clinical setting, high‐intensity interval training (HIIT) is an effective way of performing high intensity exercise. The terminology used to describe high‐intensity training unfortunately varies across research groups. Here we use the definition suggested by us recently using HIIT when the intervals’ target intensity is between 80 and 100% of peak heart rate (Weston et al. 2014), whereas more sprint‐like training, using low‐volume supramaximal (i.e. all‐out) exercise is termed sprint interval training (SIT). Nearly all clinical studies investigating the effects of higher intensity exercise have used HIIT rather than SIT. These have consistently shown that exercise using HIIT compared to moderate intensity exercise is more effective on several important prognostic factors (V˙O2 peak , ventricular function, endothelial function and quality of life) (Guiraud et al. 2012). HIIT has been found more beneficial in patients with heart failure (Wisloff et al. 2007; Freyssin et al. 2012; Guiraud et al. 2012; Fu et al. 2013; Haykowsky et al. 2013) or coronary artery disease (Rognmo et al. 2004; Moholdt et al. 2009; Guiraud et al. 2012), in individuals with the metabolic syndrome (Tjonna et al. 2008) or hypertension (Molmen‐Hansen et al. 2012), in obese individuals (Schjerve et al. 2008), and in patients with type 2 diabetes (Hollekim‐Strand et al. 2014). Also, numerous experimental animal studies support the clinical findings above, using HIIT protocols to improve health and reduce disease (Wisloff et al. 2009). Contrarily, a few experimental ‘SIT studies’ indicate detrimental effects on cardiovascular health (Holloway et al. 2015), and, in our view, more pre‐clinical trials in established animal models are warranted comparing HIIT, SIT and moderate exercise intensities on cardiovascular outcomes (including longevity) before larger randomized clinical trials should be initiated.

Application of HIIT in larger cohorts

Although the safety profile of HIIT has not been fully established, there are increasing data demonstrating that in stable and selected patients it can be performed safely with impressive improvements in physiology, functional capacity and quality of life. We recently provided the first evidence that the risk of a cardiovascular event is extremely low after both HIIT and moderate‐intensity exercise in a cardiovascular rehabilitation setting including more than 175,000 training hours (Rognmo et al. 2012). Also in a prospective study of over 12,000 US male physicians that were healthy at baseline, it was found that habitual vigorous exercise diminished the risk of sudden death during vigorous exertion (Albert et al. 2000). A recently published systematic review further supports the safety of HIIT (Levinger et al. 2015). The investigators included 11 studies with 156 patients and found the incidence of adverse responses during or within 24 h post‐exercise to be around 8%, ‘mild in nature’ and only ‘somewhat higher compared to the previously reported risk during moderate intensity continuous exercise’.

We are aware of the limitations of epidemiological studies, that they do not include purely interval based training, and the fact that they cannot establish cause–effect relationships. In addition clinical ‘HIIT studies’ are in general small and short‐term. For example, it has not been established in a randomized clinical trial that exercise training to increase V˙O2 peak leads to more and/or healthier years. Such studies are needed and at least one has been initiated including more than 1500 elderly who exercise using either moderate or high intensity where the primary outcome is mortality (Stensvold et al. 2015).

In conclusion, we believe that for over 2 billion physically inactive adults worldwide (Hallal et al. 2012), HIIT may constitute an effective way of improving health and reducing mortality, particularly since the most commonly cited barrier to physical activity is lack of time. Due to the inverse dose–response relationship between vigorous activity and mortality, we argue that HIIT should play a central role in health activity guidelines to maximize the benefits of physical activity globally. It's a HIT!

Call for comments

Readers are invited to give their views on this and the accompanying CrossTalk articles in this issue by submitting a brief (250 word) comment. Comments may be submitted up to 6 weeks after publication of the article, at which point the discussion will close and the CrossTalk authors will be invited to submit a ‘Last Word’ Please email your comment, including a title and a declaration of interest, to http://jphysiol@physoc.org. Comments will be moderated and accepted comments will be published online only as ‘supporting information’ to the original debate articles once discussion has closed.

Additional information

Competing interests

None declared.

Author contributions

All authors have approved the final version of the manuscript and agree to be accountable for all aspects of the work. All persons designated as authors qualify for authorship, and all those who qualify for authorship are listed.

Biographies

Ulrik Wisløff is a Professor in Cardiovascular Physiology and Director of the K. G. Jebsen Centre for Exercise in Medicine at the Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway. Over the last years he has built up strong, international and transdisciplinary research groups (including physiologists, molecular biologists, sociologists, nurses, physiotherapists, medical doctors, bio‐engineers, nutritionists, bio‐statisticians, epidemiologists) with more than 50 staff members (∼55% women, 30% international) (ntnu.edu/cerg).

graphic file with name TJP-593-5215-g002.gif

Øivind Rognmo is co‐director and scientist at the K. G. Jebsen Centre for Exercise in Medicine.

Jeff Coombes is a Professor in the School of Human Movement Studies at the University of Queensland, Brisbane, Australia. His research focuses on determining the optimal exercise prescription for improving health. His findings have emphasised the importance of cardiorespiratory fitness for health benefits and many of his current projects use high intensity interval training to improve fitness and investigate outcomes.

References

  1. Albert CM, Mittleman MA, Chae CU, Lee IM, Hennekens CH & Manson JE (2000). Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 343, 1355–1361. [DOI] [PubMed] [Google Scholar]
  2. Fletcher GF, Ades PA, Kligfield P, Arena R, Balady GJ, Bittner VA, Coke LA, Fleg JL, Forman DE, Gerber TC, Gulati M, Madan K, Rhodes J, Thompson PD & Williams MA; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention (2013). Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 128, 873–934. [DOI] [PubMed] [Google Scholar]
  3. Freyssin C, Verkindt C, Prieur F, Benaich P, Maunier S & Blanc P (2012). Cardiac rehabilitation in chronic heart failure: effect of an 8‐week, high‐intensity interval training versus continuous training. Arch Phys Med Rehabil 93, 1359–1364. [DOI] [PubMed] [Google Scholar]
  4. Fu TC, Wang CH, Lin PS, Hsu CC, Cherng WJ, Huang SC, Liu MH, Chiang CL & Wang JS (2013). Aerobic interval training improves oxygen uptake efficiency by enhancing cerebral and muscular hemodynamics in patients with heart failure. Int J Cardiol 167, 41–50. [DOI] [PubMed] [Google Scholar]
  5. Gebel K, Ding D, Chey T, Stamatakis E, Brown WJ & Bauman AE (2015). Effect of moderate to vigorous physical activity on all‐cause mortality in middle‐aged and older Australians. JAMA Intern Med 175, 970–977. [DOI] [PubMed] [Google Scholar]
  6. Guiraud T, Nigam A, Gremeaux V, Meyer P, Juneau M & Bosquet L (2012). High‐intensity interval training in cardiac rehabilitation. Sports Med 42, 587–605. [DOI] [PubMed] [Google Scholar]
  7. Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W & Ekelund U; Lancet Physical Activity Series Working Group (2012). Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet 380, 247–257. [DOI] [PubMed] [Google Scholar]
  8. Haykowsky MJ, Timmons MP, Kruger C, McNeely M, Taylor DA & Clark AM (2013). Meta‐analysis of aerobic interval training on exercise capacity and systolic function in patients with heart failure and reduced ejection fractions. Am J Cardiol 111, 1466–1469. [DOI] [PubMed] [Google Scholar]
  9. Hollekim‐Strand SM, Bjorgaas MR, Albrektsen G, Tjonna AE, Wisloff U & Ingul CB (2014). High‐intensity interval exercise effectively improves cardiac function in patients with type 2 diabetes mellitus and diastolic dysfunction: a randomized controlled trial. J Am Coll Cardiol 64, 1758–1760. [DOI] [PubMed] [Google Scholar]
  10. Holloway TM, Bloemberg D, da Silva ML, Simpson JA, Quadrilatero J & Spriet LL (2015). High intensity interval and endurance training have opposing effects on markers of heart failure and cardiac remodeling in hypertensive rats. PloS one 10, e0121138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Keteyian SJ, Brawner CA, Savage PD, Ehrman JK, Schairer J, Divine G, Aldred H, Ophaug K & Ades PA (2008). Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J 156, 292–300. [DOI] [PubMed] [Google Scholar]
  12. Lee DC, Sui X, Ortega FB, Kim YS, Church TS, Winett RA, Ekelund U, Katzmarzyk PT & Blair SN (2011). Comparisons of leisure‐time physical activity and cardiorespiratory fitness as predictors of all‐cause mortality in men and women. Br J Sports Med 45, 504–510. [DOI] [PubMed] [Google Scholar]
  13. Lee IM, Sesso HD, Oguma Y & Paffenbarger RS Jr (2003). Relative intensity of physical activity and risk of coronary heart disease. Circulation 107, 1110–1116. [DOI] [PubMed] [Google Scholar]
  14. Levinger I, Shaw CS, Stepto NK, Cassar S, McAinch AJ, Cheetham C & Maiorana AJ (2015). What doesn't kill you makes you fitter: a systematic review of high‐intensity interval exercise for patients with cardiovascular and metabolic diseases. Clin Med Insights Cardiol 9, 53–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Moholdt TT, Amundsen BH, Rustad LA, Wahba A, Lovo KT, Gullikstad LR, Bye A, Skogvoll E, Wisloff U & Slordahl SA (2009). Aerobic interval training versus continuous moderate exercise after coronary artery bypass surgery: a randomized study of cardiovascular effects and quality of life. Am Heart J 158, 1031–1037. [DOI] [PubMed] [Google Scholar]
  16. Molmen‐Hansen HE, Stolen T, Tjonna AE, Aamot IL, Ekeberg IS, Tyldum GA, Wisloff U, Ingul CB & Stoylen A (2012). Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients. Eur J Prev Cardiol 19, 151–160. [DOI] [PubMed] [Google Scholar]
  17. Myers J, Prakash M, Froelicher V, Do D, Partington S & Atwood JE (2002). Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346, 793–801. [DOI] [PubMed] [Google Scholar]
  18. Nes BM, Janszky I, Aspenes ST, Bertheussen GF, Vatten LJ & Wisloff U (2012). Exercise patterns and peak oxygen uptake in a healthy population: the HUNT study. Med Sci Sports Exerc 44, 1881–1889. [DOI] [PubMed] [Google Scholar]
  19. Nes BM, Vatten LJ, Nauman J, Janszky I & Wisloff U (2014). A simple nonexercise model of cardiorespiratory fitness predicts long‐term mortality. Med Sci Sports Exerc 46, 1159–1165. [DOI] [PubMed] [Google Scholar]
  20. Rognmo O, Hetland E, Helgerud J, Hoff J & Slordahl SA (2004). High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil 11, 216–222. [DOI] [PubMed] [Google Scholar]
  21. Rognmo O, Moholdt T, Bakken H, Hole T, Molstad P, Myhr NE, Grimsmo J & Wisloff U (2012). Cardiovascular risk of high‐ versus moderate‐intensity aerobic exercise in coronary heart disease patients. Circulation 126, 1436–1440. [DOI] [PubMed] [Google Scholar]
  22. Schjerve IE, Tyldum GA, Tjonna AE, Stolen T, Loennechen JP, Hansen HE, Haram PM, Heinrich G, Bye A, Najjar SM, Smith GL, Slordahl SA, Kemi OJ & Wisloff U (2008). Both aerobic endurance and strength training programmes improve cardiovascular health in obese adults. Clin Sci 115, 283–293. [DOI] [PubMed] [Google Scholar]
  23. Stensvold D, Viken H, Rognmo O, Skogvoll E, Steinshamn S, Vatten LJ, Coombes JS, Anderssen SA, Magnussen J, Ingebrigtsen JE, Fiatarone Singh MA, Langhammer A, Stoylen A, Helbostad JL & Wisloff U (2015). A randomised controlled study of the long‐term effects of exercise training on mortality in elderly people: study protocol for the Generation 100 study. BMJ Open 5, e007519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Swain DP & Franklin BA (2006). Comparison of cardioprotective benefits of vigorous versus moderate intensity aerobic exercise. Am J Cardiol 97, 141–147. [DOI] [PubMed] [Google Scholar]
  25. Tjonna AE, Lee SJ, Rognmo O, Stolen TO, Bye A, Haram PM, Loennechen JP, Al‐Share QY, Skogvoll E, Slordahl SA, Kemi OJ, Najjar SM & Wisloff U (2008). Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 118, 346–354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wen CP, Wai JP, Tsai MK, Yang YC, Cheng TY, Lee MC, Chan HT, Tsao CK, Tsai SP & Wu X (2011). Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet 378, 1244–1253. [DOI] [PubMed] [Google Scholar]
  27. Weston KS, Wisloff U & Coombes JS (2014). High‐intensity interval training in patients with lifestyle‐induced cardiometabolic disease: a systematic review and meta‐analysis. Br J Sports Med 48, 1227–1234. [DOI] [PubMed] [Google Scholar]
  28. Wisloff U, Ellingsen O & Kemi OJ (2009). High‐intensity interval training to maximize cardiac benefits of exercise training? Exerc Sport Sci Rev 37, 139–146. [DOI] [PubMed] [Google Scholar]
  29. Wisloff U, Nilsen TI, Droyvold WB, Morkved S, Slordahl SA & Vatten LJ (2006). A single weekly bout of exercise may reduce cardiovascular mortality: how little pain for cardiac gain? ‘The HUNT study, Norway’. Eur J Cardiovasc Prev Rehabil 13, 798–804. [DOI] [PubMed] [Google Scholar]
  30. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjonna AE, Helgerud J, Slordahl SA, Lee SJ, Videm V, Bye A, Smith GL, Najjar SM, Ellingsen O & Skjaerpe T (2007). Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115, 3086–3094. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES